Alpha TeknovaTKNO
TKNO
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
114% more capital invested
Capital invested by funds: $24.9M [Q3] → $53.2M (+$28.4M) [Q4]
47% more funds holding
Funds holding: 32 [Q3] → 47 (+15) [Q4]
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
2.31% more ownership
Funds ownership: 9.64% [Q3] → 11.95% (+2.31%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for TKNO.
Financial journalist opinion
Based on 4 articles about TKNO published over the past 30 days
Neutral
GlobeNewsWire
1 week ago
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies
HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx's PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova.

Neutral
GlobeNewsWire
2 weeks ago
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies
Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx's Novel PluriFreeze™ Cryopreservation System Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx's Novel PluriFreeze™ Cryopreservation System

Neutral
Seeking Alpha
3 weeks ago
Alpha Teknova, Inc. (TKNO) Q4 2024 Earnings Call Transcript
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q4 2024 Earnings Call March 4, 2025 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President, Marketing Stephen Gunstream - President and Chief Executive Officer Matt Lowell - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Matthew Parisi - KeyBanc Capital Markets Mark Massaro - BTIG Matt Hewitt - Craig-Hallum Operator Thank you for standing by, and welcome to Teknova's Fourth Quarter and Full Year 2024 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to Jennifer Henry, Senior Vice President of Marketing.

Neutral
GlobeNewsWire
3 weeks ago
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results
Full year 2024 total revenue was $37.7 million, up 3% year-over-year and in line with guidance Fourth quarter 2024 total revenue was $9.3 million, up 18% over the same quarter prior year Company provides 2025 revenue guidance of $39-42 million

Neutral
GlobeNewsWire
1 month ago
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2024, on Tuesday, March 4, 2025, following the close of market.

Neutral
Seeking Alpha
4 months ago
Alpha Teknova, Inc. (TKNO) Q3 2024 Earnings Call Transcript
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q3 2024 Earnings Conference Call November 7, 2024 5:30 PM ET Company Participants Jennifer Henry – Senior Vice President-Marketing Stephen Gunstream – President and Chief Executive Officer Matt Lowell – Chief Financial Officer Conference Call Participants Chad Wiatrowski – TD Cowen Lucas Baranowski – KeyBanc Capital Markets Vidyun Bais – BTIG Jacob Johnson – Stephens Matt Larew – William Blair Operator Hello, and welcome to Alpha Teknova Third Quarter 2024 Financial Results. At this time all participants are in a listen-only mode.

Neutral
GlobeNewsWire
4 months ago
Teknova Reports Third Quarter 2024 Financial Results
Third quarter 2024 total revenue was $9.6 million, up 17% over the same quarter prior year Company lowers 2024 total free cash outflow outlook to less than $16 million Company reaffirms 2024 revenue guidance of $35-38 million

Neutral
GlobeNewsWire
5 months ago
Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024
HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2024, on Thursday, November 7, 2024, following the close of market.

Positive
Zacks Investment Research
5 months ago
What Makes Alpha Teknova (TKNO) a Strong Momentum Stock: Buy Now?
Does Alpha Teknova (TKNO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Neutral
Seeking Alpha
7 months ago
Alpha Teknova, Inc. (TKNO) Q2 2024 Earnings Call Transcript
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2024 Earnings Conference Call August 13, 2024 5:00 PM ET Company Participants Jennifer Henry - SVP, Marketing Stephen Gunstream - President & CEO Matt Lowell - CFO Conference Call Participants Mark Massaro - BTIG Jacob Johnson - Stephens Steven Mah - TD Cowen Paul Knight - KeyBanc Matt Larew - William Blair Operator Good day and thank you for standing by. Welcome to the Teknova's Second Quarter 2024 Financial Results.

Charts implemented using Lightweight Charts™